Filter Results:
(1,203)
Show Results For
- All HBS Web
(1,203)
- People (5)
- News (334)
- Research (709)
- Events (1)
- Multimedia (17)
- Faculty Publications (457)
Show Results For
- All HBS Web
(1,203)
- People (5)
- News (334)
- Research (709)
- Events (1)
- Multimedia (17)
- Faculty Publications (457)
- March 1999 (Revised July 1999)
- Case
Dana-Farber Cancer Institute, The
By: Richard M.J. Bohmer and Ann Winslow
Describes the death of a cancer patient in one of the nation's premier cancer treatment centers and examines the organizational and process characteristics that may have contributed to the medical error. View Details
Keywords: Health Care and Treatment; Quality; Service Operations; Management Practices and Processes; Business Processes; Failure; Health Industry
Bohmer, Richard M.J., and Ann Winslow. "Dana-Farber Cancer Institute, The." Harvard Business School Case 699-025, March 1999. (Revised July 1999.)
- 16 Dec 2014
- First Look
First Look: December 16
and rehabilitative care for a patient's medical condition-is the only approach that aligns providers, payers, and suppliers in a healthy competition to increase patient value. In this article, we articulate... View Details
Keywords: Sean Silverthorne
- Article
Do We Spend Too Much on Health Care?
By: Katherine Baicker and Amitabh Chandra
Health system reforms—such as changes in insurance design, patient cost sharing, payment reform, or price regulation—should be judged by whether they move us toward higher-value use of resources, rather than by whether they reduce spending. View Details
Keywords: Health Care and Treatment; Cost; Governing Rules, Regulations, and Reforms; Value Creation
Baicker, Katherine, and Amitabh Chandra. "Do We Spend Too Much on Health Care?" New England Journal of Medicine 383, no. 7 (August 13, 2020): 605–608.
- October 2024
- Case
Allurion: Competing in the Age of GLP-1
By: Satish Tadikonda, Rajiv Lal, David Lane and Sarah Sasso
Shantanu Gaur had built Allurion into a formidable business internationally, providing obesity patients with a less invasive option long before GLP-1 drugs became the latest craze. Selling Allurion's medical device across 60+ countries, he awaited FDA approval to bring... View Details
- 25 May 2016
- Research & Ideas
How Consumers and Businesses are Reshaping Public Health
their conditions and possible treatments, often sharing their experiences with others in online communities. They are more inclined to question authority, and to raise issues with their doctors, care providers, and pharmacists. Some... View Details
- February 2000 (Revised April 2001)
- Case
Boston Medical Group
By: Richard M.J. Bohmer and Bruce L. Hall
Describes the structure of a variable compensation plan for physicians implemented by a Massachusetts medical group practice. Examines issues such as balancing group and individual risk and selection of performance metrics (productivity and patient satisfaction). View Details
Keywords: Customer Satisfaction; Health Care and Treatment; Executive Compensation; Management Practices and Processes; Risk Management; Standards; Risk and Uncertainty; Health Industry
Bohmer, Richard M.J., and Bruce L. Hall. "Boston Medical Group." Harvard Business School Case 600-086, February 2000. (Revised April 2001.)
- Article
A 680,000-Person Megastudy of Nudges to Encourage Vaccination in Pharmacies
By: Katherine L. Milkman, Linnea Gandhi, Mitesh S. Patel, Heather N. Graci, Dena M. Gromet, Hung Ho, Joseph S. Kay, Timothy W. Lee, Jake Rothschild, Jonathan E. Bogard, Ilana Brody, Christopher F. Chabris, Edward Chang, Gretchen B. Chapman, Jennifer E. Dannals, Noah J. Goldstein, Amir Goren, Hal Hershfield, Alex Hirsch, Jillian Hmurovic, Samantha Horn, Dean Karlan, Ariella S. Kristal, Cait Lamberton, Michael N. Meyer, Allison H. Oakes, Maurice E. Schweitzer, Maheen Shermohammed, Jaochim H. Talloen, Caleb Warren, Ashley V. Whillans, Kuldeep N. Yadav, Julian J. Zlatev, Ron Berman, Chalanda N. Evans, Rahul Ladhania, Jens Ludwig, Nina Mazar, Sendhil Mullainathan, Christopher K. Snider, Jann Spiess, Eli Tsukayama, Lyle Ungar, Christophe Van den Bulte, Kevin G. Volpp and Angela L. Duckworth
Encouraging vaccination is a pressing policy problem. To assess whether text-based reminders can encourage pharmacy vaccination and what kinds of messages work best, we conducted a megastudy. We randomly assigned 689,693 Walmart pharmacy patients to receive one of 22... View Details
Keywords: Vaccination; Vaccines; Nudges; Communication Strategy; Communication Technology; Consumer Behavior; Health Care and Treatment
Milkman, Katherine L., Linnea Gandhi, Mitesh S. Patel, Heather N. Graci, Dena M. Gromet, Hung Ho, Joseph S. Kay, Timothy W. Lee, Jake Rothschild, Jonathan E. Bogard, Ilana Brody, Christopher F. Chabris, Edward Chang, Gretchen B. Chapman, Jennifer E. Dannals, Noah J. Goldstein, Amir Goren, Hal Hershfield, Alex Hirsch, Jillian Hmurovic, Samantha Horn, Dean Karlan, Ariella S. Kristal, Cait Lamberton, Michael N. Meyer, Allison H. Oakes, Maurice E. Schweitzer, Maheen Shermohammed, Jaochim H. Talloen, Caleb Warren, Ashley V. Whillans, Kuldeep N. Yadav, Julian J. Zlatev, Ron Berman, Chalanda N. Evans, Rahul Ladhania, Jens Ludwig, Nina Mazar, Sendhil Mullainathan, Christopher K. Snider, Jann Spiess, Eli Tsukayama, Lyle Ungar, Christophe Van den Bulte, Kevin G. Volpp, and Angela L. Duckworth. "A 680,000-Person Megastudy of Nudges to Encourage Vaccination in Pharmacies." e2115126119. Proceedings of the National Academy of Sciences 119, no. 6 (February 8, 2022).
- June 2020
- Article
Overcoming Barriers to Early Disease Intervention
By: H. Hugo Caicedo, Daniel A. Hashimoto, Julio C. Caicedo, Alex Pentland and Gary P. Pisano
It is widely acknowledged that earlier intervention in many disease processes leads to better patient outcomes and lower treatment costs. To date, most efforts at early disease intervention have focused on "primary prevention" which focuses on preventing diseases in... View Details
Caicedo, H. Hugo, Daniel A. Hashimoto, Julio C. Caicedo, Alex Pentland, and Gary P. Pisano. "Overcoming Barriers to Early Disease Intervention." Nature Biotechnology 38, no. 6 (June 2020).
- 2012
- Working Paper
The Need for (long) Chains in Kidney Exchange
By: Itai Ashlagi, David Gamarnik, Michael A. Rees and Alvin E. Roth
It has been previously shown that for sufficiently large pools of patient-donor pairs, (almost) efficient kidney exchange can be achieved by using at most 3-way cycles, i.e., by using cycles among no more than 3 patient-donor pairs. However, as kidney exchange has... View Details
Keywords: Networks; Complexity; Performance Efficiency; Medical Specialties; Health Care and Treatment; Philanthropy and Charitable Giving
Ashlagi, Itai, David Gamarnik, Michael A. Rees, and Alvin E. Roth. "The Need for (long) Chains in Kidney Exchange." NBER Working Paper Series, No. 18202, July 2012.
- March 17, 2017
- Article
How Economics Can Shape Precision Medicines
By: Ariel Dora Stern, Brian M. Alexander and Amitabh Chandra
Many public and private efforts in coming years will focus on research in precision medicine, developing biomarkers to indicate which patients are likely to benefit from a certain treatment so that others can be spared the cost—financial and physical—of being treated... View Details
Stern, Ariel Dora, Brian M. Alexander, and Amitabh Chandra. "How Economics Can Shape Precision Medicines." Science 355, no. 6330 (March 17, 2017): 1131–1133.
- January–February 2024
- Article
Shared Service Delivery Can Increase Client Engagement: A Study of Shared Medical Appointments
By: Ryan W. Buell, Kamalini Ramdas, Nazlı Sönmez, Kavitha Srinivasan and Rengaraj Venkatesh
Problem Definition: Clients and service providers alike often consider one-on-one service delivery to be ideal, assuming – perhaps unquestioningly – that devoting individualized attention best improves client outcomes. In contrast, in shared service delivery, clients... View Details
Keywords: Health Care and Treatment; Customer Satisfaction; Outcome or Result; Performance Improvement
Buell, Ryan W., Kamalini Ramdas, Nazlı Sönmez, Kavitha Srinivasan, and Rengaraj Venkatesh. "Shared Service Delivery Can Increase Client Engagement: A Study of Shared Medical Appointments." Manufacturing & Service Operations Management 26, no. 1 (January–February 2024): 154–166.
- Article
Time-driven Activity-based Costing of Multivessel Coronary Artery Bypass Grafting across National Boundaries to Identify Improvement Opportunities: Study Protocol
By: F. Erhun, B. Mistry, T. Platcheck, A. Milstein, V.G. Narayanan and R. S. Kaplan
Coronary artery bypass graft (CABG) surgery is a common treatment for coronary artery disease—a disease that affects over 10% of US adults and is a major cause of morbidity and mortality. In 2005, the mean cost for a CABG procedure among Medicare beneficiaries in the... View Details
Keywords: Activity Based Costing and Management; Health Disorders; Health Care and Treatment; United States; India
Erhun, F., B. Mistry, T. Platcheck, A. Milstein, V.G. Narayanan, and R. S. Kaplan. "Time-driven Activity-based Costing of Multivessel Coronary Artery Bypass Grafting across National Boundaries to Identify Improvement Opportunities: Study Protocol." BMJ Open 5, no. 8 (2015).
- 28 Jun 2014
- News
Utah hospitals try the unthinkable: Get a grip on costs
Benjamin (Ben) Creo
Benjamin Creo co-teaches the Innovating in Health Care course alongside its founder, Prof. Regina E. Herzlinger. While many courses in healthcare innovation focus on where to innovate, this course focuses on how to innovate. Its four modules discuss how to evaluate... View Details
- 20 Jul 2020
- Op-Ed
It's Time for a Bipartisan Health Plan for Employers and Employees
are politically infeasible for public insurance. For example, they could offer policies that transport members for care from high-cost locations to high-quality, low-cost ones. Public insurance, in contrast, could not offer a policy that... View Details
- 21 Jun 2017
- News
A New Approach to Safely Sharing Cancer Patients’ Data
- October 2010 (Revised November 2010)
- Background Note
Plavix: Drugs in the Age of Personalized Medicine
By: Richard G. Hamermesh, Mara G. Aspinall and Rachel Gordon
PIavix, one of the world's best selling drugs in 2010, appears to have a limited future. Its patent was due to expire soon, and recently new data had been discovered that indicated that a small subset of the population would be at risk for stroke, heart attack, or even... View Details
Keywords: Health Care and Treatment; Product Positioning; Business and Government Relations; Genetics; Competitive Strategy; Pharmaceutical Industry
Hamermesh, Richard G., Mara G. Aspinall, and Rachel Gordon. "Plavix: Drugs in the Age of Personalized Medicine." Harvard Business School Background Note 811-001, October 2010. (Revised November 2010.)
- June 2010 (Revised September 2010)
- Case
athenahealth: Innovating in Response to a Crisis in Healthcare
When Jonathan Bush and his partner, Todd Park, realized that their revolutionary approach to delivering clinical care was being stymied by the inefficiencies in the healthcare system and insurance red tape, they turned their proprietary technology, athenaNet, to a new... View Details
Keywords: Entrepreneurship; Health Care and Treatment; Information Management; Innovation and Invention; Brands and Branding; Product Development; Health Industry; United States
Chakravorti, Bhaskar, Laura Winig, and Naeem Husain Arastu. "athenahealth: Innovating in Response to a Crisis in Healthcare." Harvard Business School Case 810-079, June 2010. (Revised September 2010.)
- Article
Decisions about Medication Use and Cancer Screening across Age Groups in the United States
By: Kathleen M. Fairfield, Bethany S. Gerstein, Carrie A. Levin, Vickie Stringfellow, Heidi Wierman and Mary McNaughton-Collins
Objective
To describe decision process and quality for common cancer screening and medication decisions by age group.
Methods
We included 2941 respondents to a national Internet survey who made at least one decision about colorectal, breast,... View Details
To describe decision process and quality for common cancer screening and medication decisions by age group.
Methods
We included 2941 respondents to a national Internet survey who made at least one decision about colorectal, breast,... View Details
Fairfield, Kathleen M., Bethany S. Gerstein, Carrie A. Levin, Vickie Stringfellow, Heidi Wierman, and Mary McNaughton-Collins. "Decisions about Medication Use and Cancer Screening across Age Groups in the United States." Patient Education and Counseling 98, no. 3 (March 2015): 338–343.